Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001380093 | SCV001578039 | pathogenic | Combined malonic and methylmalonic acidemia | 2023-12-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Tyr297*) in the ACSF3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACSF3 are known to be pathogenic (PMID: 21841779, 26827111). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with ACSF3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1068495). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001380093 | SCV002021716 | pathogenic | Combined malonic and methylmalonic acidemia | 2019-10-18 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001380093 | SCV002786793 | likely pathogenic | Combined malonic and methylmalonic acidemia | 2022-05-27 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001380093 | SCV004216526 | likely pathogenic | Combined malonic and methylmalonic acidemia | 2022-08-09 | criteria provided, single submitter | clinical testing |